Revolutionising 3D cell biology.

Inventia is advancing 3D bio-printing technology to revolutionise biomedical research and drug discovery.

With a strong foundation of fundamental research, Inventia has developed a proprietary platform encompassing drop-on-demand bio-printing technology, an expanding library of printable matrices and custom protocols for specific applications. The RASTRUM platform is now available to enable efficient and powerful bio-printing of 3D cell-based assays for biomedical research.